Even in the highest quartile of neighborhood socioeconomic status, Black patients were significantly less likely to receive partial nephrectomy for localized renal masses compared with White patients.
In landmark analyses, patients with recurrence by each landmark point had shorter subsequent OS compared with those who did not have recurrence.
There is no universal approach to patient selection for cytoreductive nephrectomy.
Segmental ureterectomy is increasingly adopted for high-risk upper tract urothelial carcinoma.
Investigators assessed the association between DFS and OS in patients with newly diagnosed, completely resected, intermediate-high or high-risk RCC post-nephrectomy.
As first-line therapy for advanced renal cell carcinoma, nivolumab plus cabozantinib prolongs progression-free survival compared with sunitinib in patients with and without a prior nephrectomy.
In this small study, even patients with high-risk tumors appeared to benefit from nephron-sparing surgery.
Five-year survival rates following nephrectomy for renal cell carcinoma are higher among patients with favorable vs unfavorable histology.
Neoadjuvant chemotherapy prior to radical nephroureterectomy for upper tract urothelial carcinoma may improve pathologic outcomes regardless of age, new data suggest.
New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators.
